Anthropic Launches Claude Science for Research

Anthropic announced Claude Science on Tuesday, a new flagship product aimed at supporting scientific research, mirroring the function of its Claude Code for software engineering. This advanced AI can autonomously execute complex tasks based on high-level instructions and is equipped with specialized tools for computational biology and drug development. Claude Science is now accessible to all paid Claude subscribers.

This launch signifies Anthropic's increased focus on AI applications within the life sciences. Previously, in October, the company introduced plug-ins for Claude to interact with scientific software and databases under the "Claude for Life Sciences" initiative. However, Claude Science represents a more comprehensive, standalone product, positioning it alongside other key offerings like Claude Code and Claude Cowork.

Eric Kauderer-Abrams, Anthropic's head of life sciences, stated that the development of Claude Science is central to the company's mission of advancing AI for humanity's long-term well-being, with life sciences offering the most significant opportunities. Anthropic also revealed its intention to utilize Claude Science for its own research into treatments for rare and neglected diseases.

The field of AI in science has seen significant advancements, notably from Google DeepMind, whose CEO Demis Hassabis and researcher John Jumper received the Nobel Prize in Chemistry for their work on the AlphaFold model. DeepMind has also made substantial contributions to areas such as meteorology and materials science, establishing a strong precedent for AI-driven scientific discovery.